Development of an optimized tetracycline-inducible expression system to increase the accumulation of interleukin-10 in tobacco BY-2 suspension cells

MLA

Bortesi Luisa, et al. “Development of an Optimized Tetracycline-Inducible Expression System to Increase the Accumulation of Interleukin-10 in Tobacco BY-2 Suspension Cells.” BMC Biotechnology, vol. 12, no. 1, July 2012, p. 40. EBSCOhost, https://doi.org/10.1186/1472-6750-12-40.

APA

Bortesi Luisa, Rademacher Thomas, Schiermeyer Andreas, Schuster Flora, Pezzotti Mario, & Schillberg Stefan. (2012). Development of an optimized tetracycline-inducible expression system to increase the accumulation of interleukin-10 in tobacco BY-2 suspension cells. BMC Biotechnology, 12(1), 40. https://doi.org/10.1186/1472-6750-12-40

Chicago

Bortesi Luisa, Rademacher Thomas, Schiermeyer Andreas, Schuster Flora, Pezzotti Mario, and Schillberg Stefan. 2012. “Development of an Optimized Tetracycline-Inducible Expression System to Increase the Accumulation of Interleukin-10 in Tobacco BY-2 Suspension Cells.” BMC Biotechnology 12 (1): 40. doi:10.1186/1472-6750-12-40.